SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MANGALAM DRUGS & ORGANICS

BSE: 532637 30 Sep 2025
Healthcare
₹ 75.56
Mangalam Drugs and Organics Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MANGALAM DRUGS & ORGANICS - Share Price & Details

Market Cap
₹123.0
High /Low
145.0 / 65.5
Stock P/E
17.7
Book Value
₹93.9
Dividend Yield
0.0
ROCE
8.2
ROE
₹4.76
Face Value
10.0
PEG Ratio
-0.6
EVEBITDA
₹5.77
Debt
89.2
CMP / FCF
11.0
Debt to equity
₹0.6
NP Ann
6.92
High price all time
442.0
Piotroski score
₹7.0
Graham Number
96.1
No. Eq. Shares
1.58
Net CF
₹1.57
Net profit
6.92
Price to book value
0.83
Interest Coverage
₹1.33
Low price all time
3.43
Industry PE
31.6
Reserves
₹133
Free Cash Flow
₹23.3

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
MANGALAM DRUGS & ORGANICS LTD.573.49-137.28573.49-8.67123.017.7
FORTIS MALAR HOSPITALS LIMITEDNANANANA12226.5
Murae Organisor LimitedNANANANA1197.8

Peer Comparison Chart


About MANGALAM DRUGS & ORGANICS

Mangalam Drugs and Organics Ltd., with Security Code 532637, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Mangalam Drugs Issues Corrigendum to 52nd Annual Report

(19 Sep 2025)
An update from Mangalam Drugs & Organics Ltd. ( ($IN:MANGALAM) ) is now available. Mangalam Drugs & Organics Ltd. has issued a corrigendum...
Read more →

Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma

(26 Aug 2025)
Crisil ESG Ratings & Analytics assigns ESG 57 rating to Mankind Pharma. Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating...
Read more →

Mangalam Drugs and Organics Ltd receives repeat export order worth $ 21,81,040

(23 Aug 2025)
Mangalam Drugs and Organics Limited has received a significant repeat export order from one of its reputed international clients.
Read more →

Mangalam Drugs Reports Significant Quarterly Loss

(20 Aug 2025)
Mangalam Drugs & Organics Ltd. ( ($IN:MANGALAM) ) has issued an update. Mangalam Drugs & Organics Ltd. announced its unaudited financial results for the...
Read more →

What are PDFS company’s key revenue drivers - Breakneck growth rates

(16 Aug 2025)
【Stock Observations】✌️ We help you ride the next big wave in the stock market — 200%+ gainers identified early, with real-time support.
Read more →

Mangalam Drugs Reports Decline in Sales and Profitability Amid Operational Challenges in June 2025

(11 Aug 2025)
Mangalam Drugs and Organics has reported financial results for the quarter ending June 2025, highlighting operational challenges.
Read more →